Samsung Epis Holdings Launches Its New Investment Holding as Samsung Bioepis

Kyung-Ah Kim will serve as the President and Chief Executive Officer (CEO) of Samsung Epis Holdings, in addition to her current role as the President and CEO of Samsung Bioepis (Image Courtesy: Business Wire)

Samsung Epis Holdings Co., Ltd. recently announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Samsung Biologics (KRX: 207940.KS). Samsung Epis Holdings will be listed on Korea Exchange (KRX) on November 24, 2025, after the establishment of a new subsidiary company on November 14, 2025. Samsung […]